← Leaderboards
Jianrong Li
Ohio State University
$9,360,578
Attributed
$12,973,454
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2010–25$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,024,116 · 11
By mechanism
P01$9,083,930 · 4
R01$8,427,758 · 4
R56$1,059,728 · 2
R21$452,700 · 1
Top collaborators
- Prosper N Boyaka5 shared
- Xiaoming He5 shared
- Xi Jiang5 shared
- Amal O Amer2 shared
- Estelle A Cormet-Boyaka2 shared
- Siyuan Ding1 shared
- Purnima Dubey1 shared
- Ailong Ke1 shared
Most similar at Ohio State University
Same institution · by research overlap
- Laura W Pomeroy$499,805
- Prosper N Boyaka$11,131,512
- Linda J. Saif$10,776,838
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusCellsRecombinantsViralMethyltransferaseVaccinesPathogenesisModificationIn VivoInfectionViral RnaGene ExpressionVaccine CandidateProteinsTranslationsMethylationNovel VaccinesAntiviral AgentsAttenuated VaccinesAnimal ModelAcuteEnzymesPathogenRna Caps
Grant awards (32)
Role of the Non-canonical Inflammasome in SARS-CoV-2-mediated Pathology and Coagulopathy$3,004,517
P01 · FY2025 · AI
Development of novel multivalent mucosal vaccines for human noroviruses$798,173
R01 · FY2025 · AI · contact PI
RNA epigenetic modifications in SARS-CoV-2$582,618
R01 · FY2025 · AI · contact PI
Biological Reagents and Infection Core$429,217
P01 · FY2025 · AI · contact PI
CASP-11-dependent RNA modifications and their Role in Multi-Organ Pathologies$429,216
P01 · FY2025 · AI · contact PI
RNA internal 2â-O methylation in SARS-CoV-2$199,475
R21 · FY2025 · AI · contact PI
Role of the Non-canonical Inflammasome in SARS-CoV-2-mediated Pathology and Coagulopathy$3,046,145
P01 · FY2024 · AI
CASP-11-dependent RNA modifications and their Role in Multi-Organ Pathologies$717,804
P01 · FY2024 · AI · contact PI
Biological Reagents and Infection Core$376,173
P01 · FY2024 · AI · contact PI
RNA internal 2â-O methylation in SARS-CoV-2$253,225
R21 · FY2024 · AI · contact PI
Messenger RNA capping and methylation in pneumoviruses$468,678
R01 · FY2023 · AI · contact PI
STRUCTURE-GUIDED RECEPTOR/INHIBITOR TRIMERIZATION AND RELATED STRATEGIES AGAINST CORONAVIRUSES$686,255
R56 · FY2022 · AI
Messenger RNA capping and methylation in pneumoviruses$469,038
R01 · FY2022 · AI · contact PI
Messenger RNA capping and methylation in pneumoviruses$469,386
R01 · FY2021 · AI · contact PI
A novel lactic acid bacteria-based norovirus vaccine$592,019
R01 · FY2020 · AI · contact PI
Messenger RNA capping and methylation in pneumoviruses$469,725
R01 · FY2020 · AI · contact PI
A novel lactic acid bacteria-based norovirus vaccine$597,289
R01 · FY2019 · AI · contact PI
Messenger RNA capping and methylation in pneumoviruses$498,053
R01 · FY2019 · AI · contact PI
Project 3: Dr. Li$206,648
P01 · FY2019 · AI · contact PI
A novel lactic acid bacteria-based norovirus vaccine$597,772
R01 · FY2018 · AI · contact PI
Project 3: Dr. Li$206,315
P01 · FY2018 · AI · contact PI
A novel lactic acid bacteria-based norovirus vaccine$607,519
R01 · FY2017 · AI · contact PI
Project 3: Dr. Li$267,008
P01 · FY2017 · AI · contact PI
A novel lactic acid bacteria-based norovirus vaccine$618,184
R01 · FY2016 · AI · contact PI
Project 3: Dr. Li$266,715
P01 · FY2016 · AI · contact PI
Messenger RNA Capping and Methylation in Pneumoviruses$381,250
R01 · FY2015 · AI · contact PI
Project 3: Dr. Li$134,172
P01 · FY2015 · AI · contact PI
Messenger RNA Capping and Methylation in Pneumoviruses$381,250
R01 · FY2014 · AI · contact PI
Messenger RNA Capping and Methylation in Pneumoviruses$350,002
R01 · FY2013 · AI · contact PI
Messenger RNA Capping and Methylation in Pneumoviruses$372,847
R01 · FY2012 · AI · contact PI
Messenger RNA Capping and Methylation in Pneumoviruses$173,955
R01 · FY2011 · AI · contact PI
Messenger RNA capping and methylation in pneumoviruses$373,473
R56 · FY2010 · AI · contact PI